SCHEMBL21451250

SCHEMBL21451250

CCCC(C)(C)c1cc2ccncc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.46
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
ABL1 P00519 1/20 0.41
RET P07949 1/20 0.41
PIM1 P11309 1/20 0.41
FGFR1 P11362 1/20 0.41
PRKACA P17612 1/20 0.41
FLT1 P17948 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41
KDR P35968 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41
CLK2 P49760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1612382 0.80 CYP2A6 (0.50) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL22166377 0.74 DYRK1A (0.37) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL13962344 0.72 CYP2A6 (0.67) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL12064452 0.70 CYP2A6 (0.69) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL14579467 0.70
SCHEMBL23386421 0.69 CNR1 (0.42) ROCK1CNR1CNR2
SCHEMBL12689590 0.68 CYP2A6 (0.51) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL10471093 0.68 CYP2A6 (0.59) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL30711406 0.68 CYP2A6 (0.55) CYP2A6CHEK1AURKADAPK3PRKD3
SCHEMBL965562 0.68 CYP2A6 (0.55) CYP2A6CHEK1AURKADAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME CORP. 2020-12-22 US disclosed
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10870630-B2 Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 CYP2A6 1104/4885CHEK1 1743/4885AURKA 3469/4885
US-20190308945-A1 SUBSTITUTED BICYCLIC HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA2 CYP2A6 1104/4885CHEK1 1743/4885AURKA 3469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.